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Abstract
Background: The profiles of modified nucleosides could act as useful biomarkers for cancer and cellular stress-
induced diseases. However, there are no reports of high throughput and simultaneous quantitative methods for
using biomarker evaluation and discovery at the bedside.
Methods: Modified nucleosides were separated on two CAPCELL PAK ADME S3 (100 mm × 2.1 mm i.d.; 3-μm
particle size) analytical columns coupled with a CAPCELL PAK ADME cartridge (10 mm× 2 mm i.d.; 3-μm particle
size) guard column. Both columns were used in tandem during multi-column LC analysis to reduce analysis time.
Two mobile phases were used, including 20 mM ammonium acetate adjusted to pH 5.3 using acetic acid and 1.
0 M ammonium acetate/acetonitrile/water/acetic acid (1/95/5/0.03, v/v/v/v), with the post-column addition of
methanol to enhance ionization efficiency. Tandem mass spectrometry detection was performed using a triple
quadrupole mass spectrometer equipped with a heated electrospray ionization source in selected reaction
monitoring mode.
Results: Four major nucleosides and 11 modified nucleosides, including guanosine, adenosine, uridine (U), cytidine,
inosine, 1-methyladenosine, 5-methylcytidine, 2′-O-methylcytidine, 3-methylcytidine, 7-methylguanosine (m7G), 5-
methyluridine (m5U), pseudouridine, 2-thiocytidine, N2-methylguanosine (m2G), N2,N2-dimethylguanosine, 2-fluoro-
2′-deoxyadenosine as an internal standard, and its isotopic isomers were separated within 7 min and analyzed within
10 min. This resulted in limits of quantitation of 0.50–5.00 ng mL−1, except for m2G (10.0 ng mL−1), m7G (12.5 ng mL−1),
U (12.5 ng mL−1), and m5U (50.0 ng mL−1). This method provides a wide range of linearity, with correlation coefficients
greater than 0.99 for all nucleosides. Both the accuracy and precision of this method satisfied criteria of <15% for
higher concentrations and <20% for the lowest concentrations.
Conclusions: In this study, we describe a rapid and selective method that uses multi-column liquid chromatography
with tandem mass spectrometry (LC-MS/MS) to simultaneously quantify modified nucleosides. This global analysis will
be useful for evaluating modifications in RNA.
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Background
Modified nucleosides are mainly included in transfer
RNA (tRNA) (Agris 2004), where tRNA modifications
increase conformational stability (Anderson et al. 1998),
identification (Shin et al. 2011), and translational fidelity
(Crick 1966; Gerber and Keller 1999; Agris 2015). For
example, 1-methyadenosine (m1A) is necessary for
conformational stability (Anderson et al. 1998), where
the 2-thiocytidine (s2C) occurring in the anticodon loop
interferes with the inosine–adenosine interaction (Agris
2015). As such, tRNA modification has been considered
essential for tRNA maturation and stability. Modified
nucleosides contained in most tRNA have been associ-
ated with turnover (Topp et al. 1993; Nakano et al. 1993;
Sander et al. 1986); therefore, modified nucleosides, such
as m1A, 2-methylguanosine (m2G), and pseudouridine
(Ψ), have been reported to be cancer biomarkers (Itoh et
al. 1992; Jeng et al. 2009; Djukovic et al. 2010; Cho et al.
2009). Recent studies have shown that altering the tRNA
modification profile plays a major role in the cellular
stress response (Chan et al. 2010, 2012, 2015; Endres et
al. 2015), where 5-methylcytidine (m5C), 2′-O-methylcy-
tidine (Cm), and N2,N2-dimethylguanosine (m22G) re-
portedly increase under oxidative conditions created by
H2O2; other oxidative stress reagents do not influence
these modified nucleosides (Chan et al. 2010, 2012). Al-
kylating stress affects 3-methylcytidine (m3C), where in-
creasing m3C promoted the translation of ACC- and
ACT-rich messenger RNA (Chan et al. 2015). In
addition, inosine (I), 5-methyluridine (m5U), m5C, Cm,
7-methylguanosine (m7G), and m1A were altered by rep-
lication stress (Endres et al. 2015). These cellular stress
response markers may be candidate biomarkers of cellu-
lar stress-induced diseases. The profile of modified
nucleosides could act as sensitive biomarkers for cancer
and be useful as potential biomarkers for investigating
cellular stress-induced diseases (Table 1).
A simultaneous quantitative analysis method is ne-
cessary to confirm the profile of modified nucleosides.
This is because there are many structural isomers,
regioisomers, and isotopic isomers in modified nucle-
osides, where adequate chromatographic separation is
the key to simultaneous analysis of modified nucleo-
sides. On the other hand, one of the goals of these
analytical methods is their use as biomarkers for diag-
noses at the bedside on a daily basis. In addition, bio-
marker evaluation and discovery necessitates the
analysis of large sample sizes to ensure statistical reli-
ability (Koulman et al. 2009); thus, the analytical
methods applied must have a high throughput. Ana-
lytical methods for modified nucleosides include li-
quid chromatography (LC), ultra-performance LC
(UPLC), gas chromatography, or capillary electrophor-
esis combined with ultraviolet or mass spectrometry
(MS) (Russell and Limbach 2013; Struck et al. 2011;
Lee et al. 2004; Basanta-Sanchez et al. 2016). Of these
methods, LC-tandem MS (LC-MS/MS) analysis is the
most frequently used for modified nucleoside deter-
mination due to its high selectivity and quantitative
performance. Several studies have reported good
chromatographic separation; however, these methods
require long times to separate nucleosides (Djukovic
et al. 2010; Cho et al. 2009; Struck et al. 2011; Lee et
al. 2004). Rodríguez-Gonzalo et al. (2016) reported an
analytical method that quickly and simultaneously de-
termined nucleosides; however, this method has not
been used to study significant cancer biomarkers or
cellular stress markers, such as m5C, Cm, and m22G.
Table 1 RNA modification associated with disease and cellular dysfunction
Modified nucleoside Related disease and cellular dysfunction Reference
m1A Leukemia, lymphoma, breast cancer, replication stress,
abnormal conformation of tRNA
(Anderson et al. 1998; Itoh et al. 1992; Cho et al. 2009)
I Hepatocellular carcinoma, replication stress (Jeng et al. 2009)
m2G Esophageal adenocarcinoma (Djukovic et al. 2010)
m7G Replication stress (Endres et al. 2015)
m22G Gastric cancer, intestinal cancer, lung cancer,
esophageal adenocarcinoma, breast cancer,
oxidative stress
(Nakano et al. 1993; Djukovic et al. 2010;
Cho et al. 2009; Chan et al. 2010)
m3C Alkylating stress (Chan et al. 2015)
m5C Oxidative stress, replication stress (Chan et al. 2010, 2012)
Cm Oxidative stress, replication stress (Chan et al. 2010)
s2C Interference with codon—anti-codon interaction (Agris 2015)
m5U Replication stress (Endres et al. 2015)
Ψ Gastric cancer, intestinal cancer, lung cancer, AIDS,
leukemia, lymphoma
(Nakano et al. 1993; Itoh et al. 1992)
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Basanta-Sanchez et al. (2016) demonstrated a highly
sensitive, accurate, quantitative UPLC-MS/MS nucleo-
sides analysis method; however, this method applies
to cellular RNA modifications and is thus unsuitable
for human biological samples, such as blood and
urine, due to its narrow calibration range. Several
studies have attempted to increase LC analysis
throughput, while also showing the utility of the mul-
tiple column LC method (Korfmacher et al. 1999;
Cass et al. 2001; Oertel et al. 2002; Orton et al. 2013;
Lee et al. 2015; Patel et al. 2016). This approach is
helpful for reducing the total run time without sacri-
ficing chromatographic separation, as using multiple
columns reduces separation and wash times. In this
study, we developed a rapid, selective method that
simultaneously quantifies modified nucleosides
through a multi-column LC-MS/MS system.
Methods
Chemicals
A nucleoside test mix, purchased from Sigma-Aldrich
(St. Louis, MO, USA), containing 50 μg/mL of cyti-
dine (C), 25 μg/mL of guanosine (G), 25 μg/mL of I,
25 μg/mL of m1A, 50 μg/mL of m5C, 20 μg/mL of
Cm, 100 μg/mL of m3C methosulfate, 25 μg/mL of
m7G, 100 μg/mL of m5U, 25 μg/mL of Ψ, 10 μg/mL
of s2C dehydrate, and 25 μg/mL of uridine (U) was
used. Adenosine (A) and 2-fluoro-2′-deoxyadenosine
(f2dA) were purchased from Sigma-Aldrich. m2G was
purchased from Santa Cruz Biotechnology, Inc.,
(Santa Cruz, CA, USA). m22G was purchased from
Toronto Research Chemicals (Toronto, Canada).
Methanol (MeOH) and acetonitrile (MeCN) of LC/
MS grade were obtained from Kanto Chemical
(Tokyo, Japan). LC/MS-grade ammonium acetate
(CH3COONH4) and acetic acid (CH3COOH) were ob-
tained from Wako Pure Chemical Industries.
Ultrapure-grade water was prepared using a PURE-
LAB Ultra from Organo (Tokyo, Japan).
Standard solutions
Stock standard solutions of 100 μg mL−1 for A, m2G,
m22G, m
3C, m5U, and f2dA; at 50.0 μg mL−1 for C and
m5C; at 25.0 μg mL−1 for m1A, I, G, m7G, U, and Ψ; at
20.0 μg mL−1 for Cm; and at 10.0 μg mL−1 for s2C were
prepared in 20.0 mM CH3COONH4, adjusted to a pH of
5.3 using CH3COOH. These stock solutions were stored
at −30 °C in brown glass bottles. Working solutions were
prepared by appropriate dilution of these stock solutions.
LC-MS/MS conditions
The LC system was based on a NANOSPACESI-2 LC
system (Shiseido, Tokyo, Japan), with a CAPCELL
PAK ADME S3 (100 mm × 2.1 mm i.d.; 3-μm particle
size; Shiseido, Tokyo, Japan) analytical column,
coupled with a CAPCELL PAK ADME cartridge
(10 mm × 2 mm i.d.; 3-μm particle size; Shiseido,
Tokyo, Japan) guard column. Our multiple column
LC system is composed of one auto sampler, two six-
port valves, four pumps, and two analytical columns
coupled with a guard column; this system selects the
column in line with the mass spectrometer. Both col-
umns are used in parallel during multi-column LC
analysis. One column is used as an analytical column,
while the other is washed and prepared for the next
injection. Figure 1 shows flow diagrams and valve po-
sitions of this multiple column analysis setup, where
method A is separated by column A and method B is
separated by column B. Valve A was activated to
switch between the two columns when the sample
was injected. Valve B (the MS divert valve) was
switched to MS/MS after 0.5 min of injection. All
systems were controlled via the autosampler trigger
signal. Two mobile phases were used, including
20 mM CH3COONH4 adjusted to pH 5.3 using
CH3COOH (mobile phase A) and 1.0 M
CH3COONH4/MeCN/H2O/CH3COOH (1/95/5/0.03,
v/v/v/v) (mobile phase B), with the post-column
addition of MeOH to enhance ionization efficiency.
Other LC condition parameters are summarized in
Table 2.
MS/MS detection was performed using a triple
quadrupole mass spectrometer equipped with a
heated electrospray ionization (HESI) source (TSQ
Quantum Ultra, Thermo Fisher Scientific, San Jose,
CA, USA). This system operated under the following
conditions: positive mode ionization, spray voltage
4.0 kV, vaporizer temperature 450 °C, sheath gas pres-
sure 60 psi, auxiliary pressure 40 psi, capillary
temperature 300 °C, collision gas pressure 1.0 mTorr,
tube lens offset 90 V, and collision energy 20 eV. De-
scriptions of selected reaction monitoring (SRM) tran-
sitions can be found in previous studies and are
summarized in Table 3. (Lee et al. 2004; Su et al.
2014; Fan et al. 2006) The LC-MS/MS system was
controlled by Xcalibur software (Thermo Fisher Sci-
entific), which was also used to collect data.
Calibration
All peaks were automatically integrated using the
Xcalibur software, and compound concentrations were
calculated from calibration curves describing the rela-
tionship between peak ratios and areas, using f2dA as
an internal standard (IS). Calibration curves for sys-
tem A ranged from 1.00–200 ng mL−1; specifically,
m1A ranged from 1.25–500 ng mL−1; I, G, C from
2.50–500 ng mL−1; m2G from 10.0–2000 ng mL−1;
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m5C from 0.50–500 ng mL−1; m7G, U from 12.5–
500 ng mL−1; m22G from 1.00–2000 ng mL
−1; m5U
from 50.0–2000 ng mL−1; m3C from 1.39–696 ng mL
−1; Cm from 1.00–400 ng mL−1; s2C from 4.39–
175 ng mL−1; and Ψ from 5.00–500 ng mL−1 (includ-
ing an IS of 200 ng mL−1). Calibration curve linearity
was evaluated over at least six concentrations.
Precision and accuracy
To evaluate accuracy and precision, we analyzed four
standard solution concentrations consisting of five sam-
ples on three separate days. Accuracy was calculated
from the percentage deviation of the mean from the true
value, and the precision was expressed as the relative
error and coefficient of variation (CV, %).
Results and discussion
Chromatographic separation
Our MS/MS system was used to detect four major
nucleosides and 11 modified nucleosides and f2dA
(IS), which were separated by HPLC in <10 min using
a CAPCELL PAK ADME column (Fig. 2). The result-
ant retention times using the two-column, parallel
system were as follows: C (2.30 min), U (2.71 min),
Ψ (1.56 min), m5C (2.27 min), m3C (3.63 min), Cm
(3.79 min), m5U (3.96 min), s2C (3.28 min), A
(5.15 min), I (3.61 min), m1A (2.99 min), G
(3.75 min), m7G (4.69 min), m2G (3.39 min), m22G
(5.41 min), and f2dA (IS) (6.16 min). The 10-min ana-
lytical time is half the previously reported time of
20 min (Djukovic et al. 2010; Cho et al. 2009; Russell
and Limbach 2013; Struck et al. 2011; Lee et al. 2004;
Fig. 1 Flow diagram outlining multi-column analysis. Method A is separated by column A, and method B is separated by column B. One column
is used as the analytical column, while the other column is washed and prepared for the next injection
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Basanta-Sanchez et al. 2016) Longer re-equilibration
time allows reproducibility on column separation.
However, one-third of the total analysis time was
spent on re-equilibration. To circumvent this prob-
lem, we separated re-equilibration time from total
analysis time using the multiple column system. It is
important to note that our LC system consists of the
least equipment to perform the analytical and wash
gradient compared to previous reports (Korfmacher et
al. 1999; Cass et al. 2001; Oertel et al. 2002; Orton et
al. 2013; Lee et al. 2015; Patel et al. 2016). This is
simple and easy-to-use for most LC/MS users. We
also note that the peak at 2.30 min in the chromato-
gram of U corresponds to the C + 1 isotope peak,
where our method can differentiate between the U
and C + 1 isotope peak. Additionally, this method can
differentiate between m5U for m5C + 1 and m3C + 1,
m5U for m5C + 2 and m3C + 2, and I for A + 1. Typ-
ical chromatograms for the standard solutions are
shown in Fig. 2 and demonstrate sufficient separation
using an ADME column. Simultaneous quantitative
analysis of modified nucleosides was previously performed
using the ODS column (Djukovic et al. 2010; Russell and
Limbach 2013; Lee et al. 2004; Basanta-Sanchez et al.
2016; Rodríguez-Gonzalo et al. 2016). Chromatographic
separation on the ODS column depends on the hydropho-
bic interaction, which enables separation by the number
of methyl groups (Núñez et al. 2007). However, the ODS
column is generally unsuitable for the separation of hydro-
philic compounds, such as nucleosides, because of the
weak interaction due to low surface polarity. An extended
time is required for sufficient separation of nucleosides on
the ODS column. An ADME column is composed of an
adamantyl functional group with polymer-coated silica.
While retaining the hydrophobic interaction similarly to
the ODS column, it also has higher surface polarity.
Therefore, the ADME column provides good separation
of hydrophilic compounds. In fact, separation of hydro-
philic compounds, such as amino acids, carboxylic acids,
and other hydrophilic metabolites on ADME columns has
been reported (Mochizuki et al. 2015; Uno et al. 2015;
Song et al. 2016). Using this unique surface property of
the ADME column, we achieved good chromatographic
separation of nucleosides and rapid analysis. Tubercidin
was previously used as an internal standard (Mishima et
al. 2014). However, we used f2dA because it was not
Table 2 Optimal conditions for LC analysis of nucleosides
LC system NANOSPACE SI-2 (SHISEIDO)
Analytical column CAPCELL PAK ADME
(100 × 2.1 mm i.d., 3-μm particle size, Shiseido)
Mobile phase A, 20 mM CH3COONH4/H2O
(Adjusted to pH 5.3 using CH3COOH)
B, 1.0 M CH3COONH4/MeCN/H2O/CH3COOH
=1:95:5:0.03 (v/v/v/v)
Analytical gradient 0.0–1.0 min; A/B = 100.0/0.0
1.0–4.0 min; A/B = 100.0/0.0→ 91.4/8.6
4.0–5.0 min; A/B = 91.4/8.6→ 88.6/11.4
5.0–8.0 min; A/B = 88.6/11.4→ 79.9/20.1
8.0–10.0 min; A/B = 79.9/20.1→ 0.0/100.0
Analytical flow rate 0.0–10.0 min; 400 μL/min
Wash gradient 0.0–4.0 min; A/B = 0.0/100.0
4.0–5.0 min; A/B = 0.0/100.0→ 100.0/0.0
5.0–10.0 min; A/B = 100.0/0.0
Wash flow rate 0.0–1.0 min; 400 μL/min→ 700 μL/min
1.0–4.0 min: 700 μL/min
4.0–5.0 min; 700 μL/min→ 400 μL/min
5.0–10.0 min; 400 μL/min
Post-column addition MeOH; 400 μL/min
MS divert valve 0.0–0.5 min; waste
0.5–10.0 min; detector
Oven temperature 40 °C
Injection volume 3 μL
Table 3 LC-MS/MS and calibration curve parameters for
nucleosides
Compound tR Transition Calibration range Correlation
coefficient(min) (m/z) (ng mL−1)
A 5.13 268.1→ 136.1 1.00–200 0.9993
m1A 3.01 282.1→ 150.1 1.25–500 0.9983
I 3.63 269.1→ 137.1 2.50–500 0.9987
G 3.76 284.1→ 152.1 2.50–500 0.9989
m2G 3.48 298.1→ 166.1 10.0–2000 0.9998
m7G 4.71 298.1→ 166.1 12.5–500 0.9983
m22G 5.47 312.1→ 180.1 1.00–2000 0.9999
C 2.27 244.1→ 112.1 2.50–500 0.9994
m3C 3.62 258.1→ 126.1 1.39–696a 0.9999
m5C 2.33 258.1→ 126.1 0.50–500 0.9999
Cm 3.80 258.1→ 112.1 1.00–400 0.9984
s2C 3.28 260.1→ 128.1 4.39–175b 0.9977
U 2.74 245.1→ 113.1 12.5–500 0.9979
m5U 3.99 259.1→ 127.1 50–2000 0.9973
Ψ 1.56 245.1→ 209.0 5.00–500 0.9994
f2dA (IS) 6.24 270.2→ 154.2 – –
aNucleoside test mix contained 100 μg mL−1 of 3-methylcytidine methosulfate,
and 69.6 μg mL−1 of m3C
bNucleoside test mix contained 10 μg mL−1 of 2-thiocytidine dihydrate and
8.77 μg mL−1 of s2C
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separated from other nucleosides under this chromato-
graphic condition.
Comparison of peak area ratio using multiple column LC
mode
As this method uses multiple LC columns to reduce
runtime, we evaluated column identity by investigat-
ing the ratio between target peak areas and IS area
using the two columns. No differences in area ratios
for the nucleosides using either column were detected
(Fig. 3), proving that our method can be used in
multi-column LC mode.
Limit of quantification (LOQ) and linearity
The LOQ corresponds to the lowest concentration that
is quantifiable given accuracy criteria of < ±15% and a
signal-to-noise ratio >10 AU. The LOQ for our system
was measured as 1.00–5.00 ng mL−1, except for m2G
(10.0 ng mL−1), m7G (12.5 ng mL−1), U (12.5 ng mL−1),
and m5U (50.0 ng mL−1).
Linearity
Calibration curves for all nucleosides are summa-
rized in Table 3. Correlation coefficients were greater
than 0.99 for all nucleosides, such that the calibra-
tion curves showed good linearity within the quanti-
fication range. In comparison with previous studies
(Djukovic et al. 2010; Cho et al. 2009; Lee et al.
2004; Rodríguez-Gonzalo et al. 2016), these results
suggest that our method is applicable to concentra-
tions of modified nucleosides found within biological
samples.
Accuracy and precision
The accuracy ranged from 85.05–114.7% for the highest
three concentrations and 80.03–119.6% for the lowest
concentrations across all nucleosides (Table 4). Precision
ranged from 1.073–14.84% for the highest concentrations
of all compounds and 1.731–19.92% for the lowest con-
centrations of nucleosides (Table 4). These results demon-
strate that the method presented has both good reliability
and repeatability, where data satisfied criteria of <15%
within higher concentrations and <20% within the lowest
concentrations.
Conclusions
This study describes a selective, high-throughput
method to simultaneously quantify modified nucleosides
using a novel multi-column LC-MS/MS analysis. This
method selectivity separated modified nucleosides and
Fig. 2 SRM product ion chromatograms of modified nucleoside standards in HESI positive ionization mode. SRM selected reaction monitoring,
HESI heated electrospray ionization
Fig. 3 Mean ± SE area ratio/mean area ratio (%) obtained via
multiple column LC mode. The mean area ratio was calculated from
an average of the column A and column B area ratios for each
nucleoside. SE standard error; LC: liquid chromatography
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Table 4 Accuracy and precision of nucleosides determination
Compound Nominal conc. Accuracy (%, n = 5) Precision (CV %, n = 5)
(ng mL-1) Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
A 1.00 80.89 115.1 90.92 8.695 18.96 18.77
2.00 99.87 100.4 101.6 11.39 14.22 13.4
100 103.4 106.4 98.96 9.693 13.86 4.715
200 94.53 103.4 87.53 7.254 4.434 9.463
m1A 1.25 112 99.07 92.01 17.5 17.31 18.39
2.50 98.75 104.2 89.22 14.8 13.63 6.688
250 104.7 96.29 107.4 2.781 14.01 5.248
500 105.9 99.13 100.7 5.26 12.35 3.37
I 2.50 80.03 101.2 89.46 17.17 11.15 3.536
5.00 106 95.87 104.1 14.76 11.5 11.21
250 98.16 105.8 101.3 5.065 12.14 4.513
500 85.72 89.05 98.19 4.975 4.251 9.22
G 2.50 96.91 82.1 91.72 11.76 19.92 13.07
5.00 87.73 104 104.8 13.68 8.85 13.57
250 107.2 113.4 107.5 5.877 6.036 3.147
500 98.92 109.1 101.5 6.147 4.587 4.092
m2G 10.0 112.5 104.1 106.3 14.64 14.14 6.845
20.0 91.89 102.6 104.1 7.714 13 7.213
1000 108.8 107.1 105.8 4.05 4.05 3.614
2000 101.5 100.1 97.28 8.088 8.087 4.625
m7G 12.5 101 105.7 113.6 19.92 9.69 16.52
25.0 96.96 93.67 106.4 13.45 8.244 13.57
250 101.4 112.2 96.06 5.524 4.694 7.28
500 102.9 103.3 99.69 7.926 6.845 4.815
m22G 1.00 119.6 119.1 115.9 13.68 14.68 7.302
2.00 86.04 93.41 86.09 9.516 11.8 12.52
1000 109 103.7 112.2 6.465 5.908 10.27
2000 99.07 96.76 101.6 3.59 2.827 3.27
C 2.50 82.88 106.6 117.5 18.67 17.03 7.551
5.00 114.7 94.29 107.9 14.71 8.268 14.39
250 102.4 109.3 97.02 5.971 4.065 12.05
500 96.1 102.9 95.4 1.073 2.961 9.001
m3C 1.39 84.14 111.2 106.4 19.35 13.05 8.499
3.48 104.8 113 96.75 14.17 13.6 6.68
348 105.9 104 100.4 1.999 5.678 2.158
696 92.01 95.75 94.3 3.692 12.98 4.793
m5C 0.50 81.32 106.6 117 15.81 7.609 2.149
1.00 94.27 110.2 101.8 8.507 9.095 1.588
250 93.69 95.94 93.64 3.874 5.248 6.573
500 89.01 85.05 89.83 4.385 3.218 3.484
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their isotopic isomers quickly (within 7 min), analyzing
them within 10 min using a unique multiple-column
setup, whose linearity spans a wide concentration range.
Both values of accuracy and precision satisfied criteria of
<15% for higher concentrations and <20% for the lowest
concentration. This unique method provides a fast, reli-
able means of analyzing the profile of modified nucleo-
sides, which could be used to diagnose at bedside on a
daily basis.
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